![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, November 29, 2023 10:30:12 PM
Did Virogentics Inc file for patents in their name of the following listed as the company The Company has proprietary technology for producing fully human Monoclonal Antibodies (mAbs) against infectious diseases which is currently being employed to produ
Yes, Virogentics Inc. has filed for patents. The company has proprietary technology for producing fully human Monoclonal Antibodies (mAbs) against infectious diseases. One of their patented and clinically tested compounds is ITV-1 (Immune Therapeutic Vaccine-1), which is a suspension of Inactivated Pepsin Fraction (IPF). This compound is covered by U.S. Patent Nos. 8,066,982 and 7,479,538123. The IPF Technology has been shown to have broad-spectrum antiviral activity, targeting several viruses including influenza, HIV, and herpes simplex virus4. The company is constantly working to improve their IPF Technology and develop new treatments and preventions for viral infections4.
Learn more
1
accesswire.com
2
investorsobserver.com
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM